nodes	percent_of_prediction	percent_of_DWPC	metapath
Levorphanol—Lethargy—Spironolactone—dilated cardiomyopathy	0.0362	0.0525	CcSEcCtD
Levorphanol—Renal failure—Spironolactone—dilated cardiomyopathy	0.0268	0.039	CcSEcCtD
Levorphanol—Mental disability—Furosemide—dilated cardiomyopathy	0.023	0.0335	CcSEcCtD
Levorphanol—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.0205	0.0298	CcSEcCtD
Levorphanol—Lethargy—Furosemide—dilated cardiomyopathy	0.0197	0.0286	CcSEcCtD
Levorphanol—Urinary retention—Furosemide—dilated cardiomyopathy	0.0183	0.0266	CcSEcCtD
Levorphanol—Confusional state—Spironolactone—dilated cardiomyopathy	0.0176	0.0255	CcSEcCtD
Levorphanol—Renal failure—Furosemide—dilated cardiomyopathy	0.0146	0.0212	CcSEcCtD
Levorphanol—Diplopia—Lisinopril—dilated cardiomyopathy	0.0145	0.021	CcSEcCtD
Levorphanol—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.0144	0.0208	CcSEcCtD
Levorphanol—Sweating—Furosemide—dilated cardiomyopathy	0.0142	0.0207	CcSEcCtD
Levorphanol—Urticaria—Spironolactone—dilated cardiomyopathy	0.0138	0.0201	CcSEcCtD
Levorphanol—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.0138	0.02	CcSEcCtD
Levorphanol—Visual impairment—Furosemide—dilated cardiomyopathy	0.0129	0.0187	CcSEcCtD
Levorphanol—Pruritus—Spironolactone—dilated cardiomyopathy	0.0123	0.0179	CcSEcCtD
Levorphanol—Arrhythmia—Furosemide—dilated cardiomyopathy	0.0119	0.0173	CcSEcCtD
Levorphanol—Dysuria—Lisinopril—dilated cardiomyopathy	0.0117	0.017	CcSEcCtD
Levorphanol—Dizziness—Spironolactone—dilated cardiomyopathy	0.0115	0.0167	CcSEcCtD
Levorphanol—Muscle spasms—Furosemide—dilated cardiomyopathy	0.0112	0.0162	CcSEcCtD
Levorphanol—Vomiting—Spironolactone—dilated cardiomyopathy	0.0111	0.0161	CcSEcCtD
Levorphanol—Rash—Spironolactone—dilated cardiomyopathy	0.011	0.0159	CcSEcCtD
Levorphanol—Dermatitis—Spironolactone—dilated cardiomyopathy	0.011	0.0159	CcSEcCtD
Levorphanol—Renal failure—Lisinopril—dilated cardiomyopathy	0.011	0.0159	CcSEcCtD
Levorphanol—Sweating—Lisinopril—dilated cardiomyopathy	0.0107	0.0155	CcSEcCtD
Levorphanol—Agitation—Furosemide—dilated cardiomyopathy	0.0107	0.0155	CcSEcCtD
Levorphanol—Nausea—Spironolactone—dilated cardiomyopathy	0.0103	0.015	CcSEcCtD
Levorphanol—Bradycardia—Lisinopril—dilated cardiomyopathy	0.0102	0.0148	CcSEcCtD
Levorphanol—Dry mouth—Furosemide—dilated cardiomyopathy	0.00967	0.014	CcSEcCtD
Levorphanol—Confusional state—Furosemide—dilated cardiomyopathy	0.00955	0.0139	CcSEcCtD
Levorphanol—Shock—Furosemide—dilated cardiomyopathy	0.00932	0.0135	CcSEcCtD
Levorphanol—Flushing—Lisinopril—dilated cardiomyopathy	0.00929	0.0135	CcSEcCtD
Levorphanol—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00916	0.0133	CcSEcCtD
Levorphanol—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00894	0.013	CcSEcCtD
Levorphanol—Hypotension—Furosemide—dilated cardiomyopathy	0.00885	0.0129	CcSEcCtD
Levorphanol—Tension—Lisinopril—dilated cardiomyopathy	0.00855	0.0124	CcSEcCtD
Levorphanol—Nervousness—Lisinopril—dilated cardiomyopathy	0.00846	0.0123	CcSEcCtD
Levorphanol—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00837	0.0122	CcSEcCtD
Levorphanol—Constipation—Furosemide—dilated cardiomyopathy	0.0081	0.0118	CcSEcCtD
Levorphanol—OPRD1—Peptide GPCRs—AGTR2—dilated cardiomyopathy	0.00801	0.0257	CbGpPWpGaD
Levorphanol—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00781	0.0113	CcSEcCtD
Levorphanol—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00775	0.0112	CcSEcCtD
Levorphanol—Palpitations—Lisinopril—dilated cardiomyopathy	0.0077	0.0112	CcSEcCtD
Levorphanol—Urticaria—Furosemide—dilated cardiomyopathy	0.00753	0.0109	CcSEcCtD
Levorphanol—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00749	0.0109	CcSEcCtD
Levorphanol—OPRD1—Peptide GPCRs—CXCR3—dilated cardiomyopathy	0.00745	0.0239	CbGpPWpGaD
Levorphanol—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00725	0.0105	CcSEcCtD
Levorphanol—Confusional state—Lisinopril—dilated cardiomyopathy	0.00717	0.0104	CcSEcCtD
Levorphanol—OPRK1—Peptide GPCRs—AGTR2—dilated cardiomyopathy	0.00703	0.0226	CbGpPWpGaD
Levorphanol—OPRD1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00703	0.0226	CbGpPWpGaD
Levorphanol—Shock—Lisinopril—dilated cardiomyopathy	0.00699	0.0102	CcSEcCtD
Levorphanol—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00694	0.0101	CcSEcCtD
Levorphanol—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00687	0.00998	CcSEcCtD
Levorphanol—Pruritus—Furosemide—dilated cardiomyopathy	0.0067	0.00973	CcSEcCtD
Levorphanol—Hypotension—Lisinopril—dilated cardiomyopathy	0.00664	0.00964	CcSEcCtD
Levorphanol—OPRK1—Peptide GPCRs—CXCR3—dilated cardiomyopathy	0.00653	0.021	CbGpPWpGaD
Levorphanol—Insomnia—Lisinopril—dilated cardiomyopathy	0.00643	0.00933	CcSEcCtD
Levorphanol—Dizziness—Furosemide—dilated cardiomyopathy	0.00627	0.0091	CcSEcCtD
Levorphanol—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00626	0.00908	CcSEcCtD
Levorphanol—OPRD1—Peptide GPCRs—AGTR1—dilated cardiomyopathy	0.00616	0.0198	CbGpPWpGaD
Levorphanol—OPRK1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00616	0.0198	CbGpPWpGaD
Levorphanol—Constipation—Lisinopril—dilated cardiomyopathy	0.00608	0.00883	CcSEcCtD
Levorphanol—Vomiting—Furosemide—dilated cardiomyopathy	0.00602	0.00875	CcSEcCtD
Levorphanol—Rash—Furosemide—dilated cardiomyopathy	0.00597	0.00867	CcSEcCtD
Levorphanol—Dermatitis—Furosemide—dilated cardiomyopathy	0.00597	0.00866	CcSEcCtD
Levorphanol—OPRM1—Peptide GPCRs—AGTR2—dilated cardiomyopathy	0.00594	0.0191	CbGpPWpGaD
Levorphanol—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00586	0.0085	CcSEcCtD
Levorphanol—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00581	0.00844	CcSEcCtD
Levorphanol—Urticaria—Lisinopril—dilated cardiomyopathy	0.00565	0.0082	CcSEcCtD
Levorphanol—Nausea—Furosemide—dilated cardiomyopathy	0.00563	0.00817	CcSEcCtD
Levorphanol—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00562	0.00816	CcSEcCtD
Levorphanol—OPRM1—Peptide GPCRs—CXCR3—dilated cardiomyopathy	0.00552	0.0177	CbGpPWpGaD
Levorphanol—OPRK1—Peptide GPCRs—AGTR1—dilated cardiomyopathy	0.0054	0.0174	CbGpPWpGaD
Levorphanol—OPRM1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00521	0.0167	CbGpPWpGaD
Levorphanol—Pruritus—Lisinopril—dilated cardiomyopathy	0.00503	0.0073	CcSEcCtD
Levorphanol—Dizziness—Lisinopril—dilated cardiomyopathy	0.0047	0.00682	CcSEcCtD
Levorphanol—OPRM1—Peptide GPCRs—AGTR1—dilated cardiomyopathy	0.00457	0.0147	CbGpPWpGaD
Levorphanol—Vomiting—Lisinopril—dilated cardiomyopathy	0.00452	0.00656	CcSEcCtD
Levorphanol—Rash—Lisinopril—dilated cardiomyopathy	0.00448	0.00651	CcSEcCtD
Levorphanol—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00448	0.0065	CcSEcCtD
Levorphanol—OPRM1—IL4-mediated signaling events—IL10—dilated cardiomyopathy	0.00441	0.0142	CbGpPWpGaD
Levorphanol—OPRM1—IL4-mediated signaling events—RPS6KB1—dilated cardiomyopathy	0.00429	0.0138	CbGpPWpGaD
Levorphanol—Nausea—Lisinopril—dilated cardiomyopathy	0.00422	0.00613	CcSEcCtD
Levorphanol—OPRD1—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.00377	0.0121	CbGpPWpGaD
Levorphanol—OPRD1—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.00377	0.0121	CbGpPWpGaD
Levorphanol—OPRD1—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.0035	0.0113	CbGpPWpGaD
Levorphanol—OPRK1—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.0033	0.0106	CbGpPWpGaD
Levorphanol—OPRK1—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.0033	0.0106	CbGpPWpGaD
Levorphanol—OPRD1—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00318	0.0102	CbGpPWpGaD
Levorphanol—OPRD1—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00318	0.0102	CbGpPWpGaD
Levorphanol—OPRK1—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.00307	0.00987	CbGpPWpGaD
Levorphanol—OPRD1—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00296	0.0095	CbGpPWpGaD
Levorphanol—OPRD1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00295	0.00948	CbGpPWpGaD
Levorphanol—OPRM1—TCR Signaling Pathway—FAS—dilated cardiomyopathy	0.00293	0.00942	CbGpPWpGaD
Levorphanol—OPRD1—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.0029	0.00931	CbGpPWpGaD
Levorphanol—OPRM1—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.00279	0.00897	CbGpPWpGaD
Levorphanol—OPRM1—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.00279	0.00897	CbGpPWpGaD
Levorphanol—OPRK1—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00279	0.00896	CbGpPWpGaD
Levorphanol—OPRK1—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00279	0.00896	CbGpPWpGaD
Levorphanol—OPRD1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00274	0.00881	CbGpPWpGaD
Levorphanol—OPRD1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00266	0.00854	CbGpPWpGaD
Levorphanol—OPRM1—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.0026	0.00834	CbGpPWpGaD
Levorphanol—OPRK1—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00259	0.00833	CbGpPWpGaD
Levorphanol—OPRK1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00259	0.00831	CbGpPWpGaD
Levorphanol—OPRK1—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.00254	0.00817	CbGpPWpGaD
Levorphanol—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00253	0.00812	CbGpPWpGaD
Levorphanol—OPRD1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00253	0.00812	CbGpPWpGaD
Levorphanol—OPRK1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00241	0.00773	CbGpPWpGaD
Levorphanol—OPRM1—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00236	0.00757	CbGpPWpGaD
Levorphanol—OPRM1—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00236	0.00757	CbGpPWpGaD
Levorphanol—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00235	0.00755	CbGpPWpGaD
Levorphanol—OPRK1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00233	0.00748	CbGpPWpGaD
Levorphanol—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00228	0.00731	CbGpPWpGaD
Levorphanol—OPRD1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00227	0.00729	CbGpPWpGaD
Levorphanol—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00222	0.00712	CbGpPWpGaD
Levorphanol—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00222	0.00712	CbGpPWpGaD
Levorphanol—OPRM1—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00219	0.00704	CbGpPWpGaD
Levorphanol—OPRM1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00219	0.00703	CbGpPWpGaD
Levorphanol—OPRD1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00215	0.00692	CbGpPWpGaD
Levorphanol—OPRM1—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.00215	0.0069	CbGpPWpGaD
Levorphanol—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00206	0.00662	CbGpPWpGaD
Levorphanol—OPRD1—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.00204	0.00655	CbGpPWpGaD
Levorphanol—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00203	0.00653	CbGpPWpGaD
Levorphanol—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.002	0.00641	CbGpPWpGaD
Levorphanol—OPRK1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00199	0.00639	CbGpPWpGaD
Levorphanol—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00197	0.00633	CbGpPWpGaD
Levorphanol—OPRD1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00194	0.00625	CbGpPWpGaD
Levorphanol—OPRD1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00192	0.00619	CbGpPWpGaD
Levorphanol—OPRD1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00192	0.00619	CbGpPWpGaD
Levorphanol—OPRM1—TCR Signaling Pathway—RAF1—dilated cardiomyopathy	0.00191	0.00613	CbGpPWpGaD
Levorphanol—OPRK1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00189	0.00606	CbGpPWpGaD
Levorphanol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00187	0.00602	CbGpPWpGaD
Levorphanol—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00187	0.00602	CbGpPWpGaD
Levorphanol—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00184	0.00593	CbGpPWpGaD
Levorphanol—OPRD1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00179	0.00575	CbGpPWpGaD
Levorphanol—OPRK1—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.00179	0.00575	CbGpPWpGaD
Levorphanol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00174	0.0056	CbGpPWpGaD
Levorphanol—OPRD1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00173	0.00557	CbGpPWpGaD
Levorphanol—OPRD1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00172	0.00553	CbGpPWpGaD
Levorphanol—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.0017	0.00548	CbGpPWpGaD
Levorphanol—OPRK1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00169	0.00542	CbGpPWpGaD
Levorphanol—OPRK1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00169	0.00542	CbGpPWpGaD
Levorphanol—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00169	0.00542	CbGpPWpGaD
Levorphanol—OPRM1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00168	0.0054	CbGpPWpGaD
Levorphanol—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00162	0.0052	CbGpPWpGaD
Levorphanol—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00159	0.00513	CbGpPWpGaD
Levorphanol—OPRK1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00157	0.00504	CbGpPWpGaD
Levorphanol—OPRK1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00152	0.00488	CbGpPWpGaD
Levorphanol—OPRM1—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.00151	0.00486	CbGpPWpGaD
Levorphanol—OPRK1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00151	0.00485	CbGpPWpGaD
Levorphanol—OPRD1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00148	0.00476	CbGpPWpGaD
Levorphanol—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00144	0.00463	CbGpPWpGaD
Levorphanol—OPRM1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00143	0.00458	CbGpPWpGaD
Levorphanol—OPRM1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00143	0.00458	CbGpPWpGaD
Levorphanol—OPRD1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.0014	0.00451	CbGpPWpGaD
Levorphanol—OPRD1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00137	0.0044	CbGpPWpGaD
Levorphanol—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00137	0.00439	CbGpPWpGaD
Levorphanol—OPRM1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00133	0.00426	CbGpPWpGaD
Levorphanol—OPRK1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.0013	0.00417	CbGpPWpGaD
Levorphanol—OPRM1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00128	0.00413	CbGpPWpGaD
Levorphanol—OPRM1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00127	0.0041	CbGpPWpGaD
Levorphanol—OPRK1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00123	0.00396	CbGpPWpGaD
Levorphanol—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.0012	0.00385	CbGpPWpGaD
Levorphanol—OPRM1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.0011	0.00352	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00109	0.0035	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00109	0.0035	CbGpPWpGaD
Levorphanol—OPRD1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00104	0.00335	CbGpPWpGaD
Levorphanol—OPRM1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00104	0.00334	CbGpPWpGaD
Levorphanol—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00101	0.00326	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00101	0.00325	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000988	0.00317	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000988	0.00317	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000979	0.00315	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000954	0.00307	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000954	0.00307	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000918	0.00295	CbGpPWpGaD
Levorphanol—OPRK1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000913	0.00293	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000889	0.00286	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000887	0.00285	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000866	0.00278	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000866	0.00278	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000859	0.00276	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000836	0.00269	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000806	0.00259	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000806	0.00259	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000805	0.00259	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000794	0.00255	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00078	0.00251	CbGpPWpGaD
Levorphanol—OPRM1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000772	0.00248	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00076	0.00244	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000749	0.00241	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000733	0.00236	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000732	0.00235	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000732	0.00235	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000726	0.00233	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000721	0.00232	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000696	0.00224	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000681	0.00219	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000666	0.00214	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000659	0.00212	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000657	0.00211	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000632	0.00203	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00062	0.00199	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000616	0.00198	CbGpPWpGaD
Levorphanol—OPRD1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000589	0.00189	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000588	0.00189	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000584	0.00188	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000584	0.00188	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000576	0.00185	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000563	0.00181	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000559	0.0018	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000542	0.00174	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00054	0.00174	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000535	0.00172	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000534	0.00172	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000525	0.00169	CbGpPWpGaD
Levorphanol—OPRK1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000516	0.00166	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000512	0.00164	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000512	0.00164	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000491	0.00158	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000487	0.00157	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000476	0.00153	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000469	0.00151	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000461	0.00148	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000457	0.00147	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000449	0.00144	CbGpPWpGaD
Levorphanol—OPRM1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000436	0.0014	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000432	0.00139	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000432	0.00139	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000426	0.00137	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000415	0.00133	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000402	0.00129	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000396	0.00127	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000393	0.00126	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000389	0.00125	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000373	0.0012	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000371	0.00119	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000366	0.00118	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000333	0.00107	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.00033	0.00106	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000325	0.00105	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000321	0.00103	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—AGT—dilated cardiomyopathy	0.000316	0.00101	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000315	0.00101	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.00029	0.000931	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—AGT—dilated cardiomyopathy	0.000277	0.00089	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000275	0.000883	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000271	0.000871	CbGpPWpGaD
Levorphanol—OPRD1—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000254	0.000817	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000245	0.000787	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—AGT—dilated cardiomyopathy	0.000234	0.000752	CbGpPWpGaD
Levorphanol—OPRK1—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000223	0.000717	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000219	0.000704	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000192	0.000617	CbGpPWpGaD
Levorphanol—OPRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000189	0.000606	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000162	0.000522	CbGpPWpGaD
Levorphanol—OPRD1—Signaling Pathways—EGFR—dilated cardiomyopathy	0.00015	0.000483	CbGpPWpGaD
Levorphanol—OPRK1—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000132	0.000423	CbGpPWpGaD
Levorphanol—OPRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000111	0.000358	CbGpPWpGaD
